Screener
Charles River Laboratories CRL RMS — Total
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| RMS | $7,748 | $7,419 | $25,380 | $8,843 |
| DSA | 7,007 | 16,076 | 13,887 | 33,618 |
| Manufacturing | 717 | 7,444 | 1,179 | 11,155 |
| Unallocated corporate | 7,585 | 1,261 | 14,191 | 2,429 |
| Total | $23,057 | $32,200 | $54,637 | $56,045 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's RMS — total?
- Charles River Laboratories (CRL) reported RMS — total of $7.75M in Q2 2026.
- How has Charles River Laboratories's RMS — total changed year-over-year?
- Charles River Laboratories's RMS — total increased by 4.4% year-over-year, from $7.42M to $7.75M.
- What is the long-term trend for Charles River Laboratories's RMS — total?
- Over 2 years (2023 to 2025), Charles River Laboratories's RMS — total has grown at a 131.9% compound annual growth rate (CAGR), from $3.48M to $18.71M.
- What does RMS — total mean?
- This metric represents the aggregate value of specific non-operating or miscellaneous costs associated with the Research Models and Services segment. It serves as a catch-all for items that do not fit into standard operating expense categories.
Ask your AI about Charles River Laboratories's rms — total.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude